New MRI scanner aims to sharpen breast tumor measurements
NCT ID NCT07492043
First seen Apr 08, 2026 · Last updated May 23, 2026 · Updated 4 times
Summary
This study tests a new type of MRI scanner, called Field-Cycling Imaging (FCI), to see if it can more accurately measure the size of breast tumors in people with ductal carcinoma in situ (DCIS). About 12 participants will have both a standard MRI and an FCI scan before their surgery. The goal is to compare the FCI measurements with the actual tumor size found after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Aberdeen
Aberdeen, United Kingdom
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.